Literature DB >> 21813603

Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.

Jany Chan1, Robert A Dick, Volker M Vogt.   

Abstract

The MA domain of the retroviral Gag protein mediates interactions with the plasma membrane, which is the site of productive virus release. HIV-1 MA has a phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P₂] binding pocket; depletion of this phospholipid from the plasma membrane compromises Gag membrane association and virus budding. We used multiple methods to examine the possible role of PI(4,5)P₂ in Gag-membrane interaction of the alpharetrovirus Rous sarcoma virus (RSV). In contrast to HIV-1, which was tested in parallel, neither membrane localization of RSV Gag-GFP nor release of virus-like particles was affected by phosphatase-mediated depletion of PI(4,5)P₂ in transfected avian cells. In liposome flotation experiments, RSV Gag required acidic lipids for binding but showed no specificity for PI(4,5)P₂. Mono-, di-, and triphosphorylated phosphatidylinositol phosphate (PIP) species as well as high concentrations of phosphatidylserine (PS) supported similar levels of flotation. A mutation that increases the overall charge of RSV MA also enhanced Gag membrane binding. Contrary to previous reports, we found that high concentrations of PS, in the absence of PIPs, also strongly promoted HIV-1 Gag flotation. Taken together, we interpret these results to mean that RSV Gag membrane association is driven by electrostatic interactions and not by any specific association with PI(4,5)P₂.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813603      PMCID: PMC3187501          DOI: 10.1128/JVI.00760-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

2.  Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.

Authors:  Ayna Alfadhli; Amelia Still; Eric Barklis
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

3.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

4.  Characterization of a myristoylated, monomeric HIV Gag protein.

Authors:  Jun Dou; Jaang-Jiun Wang; Xuemin Chen; Hua Li; Lingmei Ding; Paul Spearman
Journal:  Virology       Date:  2009-03-12       Impact factor: 3.616

5.  Differential roles of phosphatidylserine, PtdIns(4,5)P2, and PtdIns(3,4,5)P3 in plasma membrane targeting of C2 domains. Molecular dynamics simulation, membrane binding, and cell translocation studies of the PKCalpha C2 domain.

Authors:  Debasis Manna; Nitin Bhardwaj; Mohsin S Vora; Robert V Stahelin; Hui Lu; Wonhwa Cho
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

6.  Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding.

Authors:  Vineela Chukkapalli; Ian B Hogue; Vitaly Boyko; Wei-Shau Hu; Akira Ono
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides.

Authors:  Robin Chan; Pradeep D Uchil; Jing Jin; Guanghou Shui; David E Ott; Walther Mothes; Markus R Wenk
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.

Authors:  E Hamard-Peron; F Juillard; J S Saad; C Roy; P Roingeard; M F Summers; J-L Darlix; C Picart; D Muriaux
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

9.  Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2.

Authors:  Kang Chen; Indra Bachtiar; Grzegorz Piszczek; Fadila Bouamr; Carol Carter; Nico Tjandra
Journal:  Biochemistry       Date:  2008-01-26       Impact factor: 3.162

10.  Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.

Authors:  Jamil S Saad; Sherimay D Ablan; Ruba H Ghanam; Andrew Kim; Kalola Andrews; Kunio Nagashima; Ferri Soheilian; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

View more
  30 in total

1.  Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and Dependent on the Spacer Peptide Assembly Domain.

Authors:  Robert A Dick; Marilia Barros; Danni Jin; Mathias Lösche; Volker M Vogt
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

2.  Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 matrix domain proteins.

Authors:  Robert A Dick; Elena Kamynina; Volker M Vogt
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

3.  Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.

Authors:  Marilia Barros; Frank Heinrich; Siddhartha A K Datta; Alan Rein; Ioannis Karageorgos; Hirsh Nanda; Mathias Lösche
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

4.  How HIV finds the door.

Authors:  Matthew Scott Lalonde; Wesley I Sundquist
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-01       Impact factor: 11.205

5.  Evidence in support of RNA-mediated inhibition of phosphatidylserine-dependent HIV-1 Gag membrane binding in cells.

Authors:  Vineela Chukkapalli; Jingga Inlora; Gabrielle C Todd; Akira Ono
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

6.  Effects of Membrane Charge and Order on Membrane Binding of the Retroviral Structural Protein Gag.

Authors:  Yi Wen; Robert A Dick; Gerald W Feigenson; Volker M Vogt
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

7.  Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.

Authors:  Tiffiny D Rye-McCurdy; Shorena Nadaraia-Hoke; Nicole Gudleski-O'Regan; John M Flanagan; Leslie J Parent; Karin Musier-Forsyth
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

8.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  HIV-1 Gag associates with specific uropod-directed microdomains in a manner dependent on its MA highly basic region.

Authors:  G Nicholas Llewellyn; Jonathan R Grover; Balaji Olety; Akira Ono
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

Review 10.  Roles played by acidic lipids in HIV-1 Gag membrane binding.

Authors:  Balaji Olety; Akira Ono
Journal:  Virus Res       Date:  2014-07-03       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.